Danaher Corporation – NYSE:DHR-PB
Danaher stock price today
Danaher stock price monthly change
Danaher stock price quarterly change
Danaher stock price yearly change
Danaher key metrics
Market Cap | 916.75B |
Enterprise value | 181.81B |
P/E | 42.93 |
EV/Sales | 9.07 |
EV/EBITDA | 25.40 |
Price/Sales | 8.33 |
Price/Book | 3.25 |
PEG ratio | 19.42 |
EPS | 5.96 |
Revenue | 22.51B |
EBITDA | 6.65B |
Income | 4.40B |
Revenue Q/Q | -19.12% |
Revenue Y/Y | -27.24% |
Profit margin | 19.43% |
Oper. margin | 19.87% |
Gross margin | 59.61% |
EBIT margin | 19.87% |
EBITDA margin | 29.57% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeDanaher stock price history
Danaher stock forecast
Danaher financial statements
| Jun 2023 | 7.15B | 1.10B | 15.45% |
|---|---|---|---|
| Sep 2023 | 6.87B | 1.12B | 16.43% |
| Dec 2023 | 2.69B | 1.07B | 40.07% |
| Mar 2024 | 5.79B | 1.08B | 18.77% |
| Payout ratio | 19.86% |
|---|
| 2019 | 0.54% |
|---|---|
| 2020 | 0.44% |
| 2021 | 0.36% |
| 2022 | 0.48% |
| 2023 | 0.48% |
| Jun 2023 | 84902000000 | 33.17B | 39.08% |
|---|---|---|---|
| Sep 2023 | 87734000000 | 35.31B | 40.26% |
| Dec 2023 | 84488000000 | 30.99B | 36.69% |
| Mar 2024 | 83402000000 | 29.95B | 35.92% |
| Jun 2023 | 1.92B | -431M | -208M |
|---|---|---|---|
| Sep 2023 | 1.67B | -329M | 2.44B |
| Dec 2023 | 1.61B | -6.01B | -2.24B |
| Mar 2024 | 1.73B | -321M | -133M |
Danaher alternative data
| Aug 2023 | 79,000 |
|---|---|
| Sep 2023 | 79,000 |
| Oct 2023 | 79,000 |
| Nov 2023 | 79,000 |
| Dec 2023 | 79,000 |
| Jan 2024 | 79,000 |
| Feb 2024 | 79,000 |
| Mar 2024 | 79,000 |
| Apr 2024 | 79,000 |
| May 2024 | 79,000 |
| Jun 2024 | 79,000 |
| Jul 2024 | 79,000 |
Danaher other data
| Period | Buy | Sel |
|---|---|---|
| Feb 2022 | 0 | 5365 |
| Apr 2022 | 0 | 6500 |
| May 2022 | 100 | 0 |
| Jul 2022 | 0 | 15906 |
| Aug 2022 | 0 | 25000 |
| Oct 2022 | 0 | 500 |
| Nov 2022 | 0 | 30816 |
| Jan 2023 | 0 | 2230 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | STEVENS RAYMOND C director | Director stock option (right to buy) | 2,230 | $131.05 | $292,242 | ||
Sale | STEVENS RAYMOND C director | Common Stock | 2,230 | $264.24 | $589,244 | ||
Option | STEVENS RAYMOND C director | Common Stock | 2,230 | $131.05 | $292,242 | ||
Option | STEVENS RAYMOND C director | Common Stock | 2,640 | $100.24 | $264,634 | ||
Option | STEVENS RAYMOND C director | Common Stock | 3,540 | $83.28 | $294,811 | ||
Option | WEIDEMANIS JOAKIM officer: Executiv.. | Employee stock option (right to buy) | 6,608 | $57.9 | $382,603 | ||
Option | WEIDEMANIS JOAKIM officer: Executiv.. | Employee stock option (right to buy) | 6,608 | $57.9 | $382,603 | ||
Option | WEIDEMANIS JOAKIM officer: Executiv.. | Employee stock option (right to buy) | 6,608 | $57.9 | $382,603 | ||
Sale | WEIDEMANIS JOAKIM officer: Executiv.. | Common Stock | 2,900 | $266.98 | $774,242 | ||
Sale | WEIDEMANIS JOAKIM officer: Executiv.. | Common Stock | 2,900 | $266.98 | $774,242 |
-
What's the price of Danaher stock today?
One share of Danaher stock can currently be purchased for approximately $1,669.45.
-
When is Danaher's next earnings date?
Unfortunately, Danaher's (DHR-PB) next earnings date is currently unknown.
-
Does Danaher pay dividends?
Yes, Danaher pays dividends and its trailing 12-month yield is 0.47% with 20% payout ratio. The last Danaher stock dividend of $12.5 was paid on 7 Sep 2025.
-
How much money does Danaher make?
Danaher has a market capitalization of 916.75B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 24.09% to 23.89B US dollars.
-
What is Danaher's stock symbol?
Danaher Corporation is traded on the NYSE under the ticker symbol "DHR-PB".
-
What is Danaher's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Danaher?
Shares of Danaher can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Danaher's key executives?
Danaher's management team includes the following people:
- Mr. Rainer M. Blair Pres, Chief Executive Officer & Director(age: 61, pay: $3,810,000)
- Ms. Angela S. Lalor Senior Vice President of HR(age: 60, pay: $3,110,000)
- Mr. Joakim Weidemanis Executive Vice President(age: 56, pay: $2,940,000)
- Mr. Matthew R. McGrew Chief Financial Officer & Executive Vice President(age: 53, pay: $2,460,000)
- Mr. Brian W. Ellis Senior Vice President, Gen. Counsel & Chief Compliance Officer(age: 58, pay: $1,930,000)
-
How many employees does Danaher have?
As Jul 2024, Danaher employs 79,000 workers.
-
When Danaher went public?
Danaher Corporation is publicly traded company for more then 5 years since IPO on 11 May 2020.
-
What is Danaher's official website?
The official website for Danaher is danaher.com.
-
Where are Danaher's headquarters?
Danaher is headquartered at 2200 Pennsylvania Avenue, NW, Washington, DC.
-
How can i contact Danaher?
Danaher's mailing address is 2200 Pennsylvania Avenue, NW, Washington, DC and company can be reached via phone at +20 2 8280850.
Danaher company profile:
Danaher Corporation
danaher.comNYSE
79,000
Medical - Diagnostics & Research
Healthcare
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Washington, DC 20037-1701
CIK: 0000313616
ISIN: US2358514097
CUSIP: 235851409
